Drug Profile
Research programme: abuse-resistant opioid analgesics - Atlantic Pharmaceuticals
Alternative Names: ATLP-02; ATLP-03Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Atlantic Pharmaceuticals
- Class Morphine derivatives; Opioid analgesics; Small molecules
- Mechanism of Action Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Pain in USA (PO, Immediate release)
- 23 Jun 2009 Preclinical trials in Pain in USA (PO)